Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.
Sim WJ, Iyengar PV, Lama D, Lui SKL, Ng HC, Haviv-Shapira L, Domany E, Kappei D, Tan TZ, Saei A, Jaynes PW, Verma CS, Kumar AP, Rouanne M, Ha HK, Radulescu C, Ten Dijke P, Eichhorn PJA, Thiery JP. Sim WJ, et al. Among authors: rouanne m. Nat Commun. 2019 Nov 8;10(1):5148. doi: 10.1038/s41467-019-13095-4. Nat Commun. 2019. PMID: 31704935 Free PMC article.
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytology.
Neuzillet Y, Methorst C, Schneider M, Lebret T, Rouanne M, Radulescu C, Molinie V, Dreyfus JF, Pelcat V, Botto H. Neuzillet Y, et al. Among authors: rouanne m. Urol Oncol. 2014 Nov;32(8):1135-40. doi: 10.1016/j.urolonc.2014.04.005. Epub 2014 Jul 9. Urol Oncol. 2014. PMID: 25023786 Clinical Trial.
Re: Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications: S. A. M. Wankowicz, L. Werner, A. Orsola, J. Novak, M. Bowden, T. K. Choueiri, I. de Torres, J. Morote, G. J. Freeman, S. Signoretti and J. Bellmunt J Urol 2017;198:817-823.
Rouanne M, Lebret T, Radulescu C, Adam J. Rouanne M, et al. J Urol. 2018 Mar;199(3):854-856. doi: 10.1016/j.juro.2017.09.145. Epub 2017 Nov 24. J Urol. 2018. PMID: 29179001 No abstract available.
Reply to Pontus Eriksson and Gottfrid Sjödahl's Letter to the Editor re: Tuan Zea Tan, Mathieu Rouanne, Kien Thiam Tan, Ruby Yun-Ju Huang, Jean-Paul Thiery. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors. Eur Urol 2019;75:423-32.
Tan TZ, Rouanne M, Huang RY, Thiery JP. Tan TZ, et al. Among authors: rouanne m. Eur Urol. 2019 Apr;75(4):e108-e109. doi: 10.1016/j.eururo.2018.11.048. Epub 2018 Dec 5. Eur Urol. 2019. PMID: 30527788 No abstract available.
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.
Simon M, Bosset PO, Rouanne M, Benhamou S, Radulescu C, Molinié V, Neuzillet Y, Paoletti X, Lebret T. Simon M, et al. Among authors: rouanne m. PLoS One. 2019 Feb 27;14(2):e0211721. doi: 10.1371/journal.pone.0211721. eCollection 2019. PLoS One. 2019. PMID: 30811419 Free PMC article.
83 results